Montag A & Associates Inc Amgen Inc Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 3,701 shares of AMGN stock, worth $978,877. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,701
Previous 5,718 35.27%
Holding current value
$978,877
Previous $1.79 Million 33.26%
% of portfolio
0.06%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$309.38 - $337.38 $624,019 - $680,495
-2,017 Reduced 35.27%
3,701 $1.19 Million
Q2 2024

Jul 31, 2024
SELL
$262.75 - $319.31 $14,976 - $18,200
-57 Reduced 0.99%
5,718 $1.79 Million
Q1 2024

May 07, 2024
BUY
$268.87 - $324.56 $712,505 - $860,084
2,650 Added 84.8%
5,775 $1.64 Million
Q4 2023

Feb 07, 2024
SELL
$255.7 - $288.46 $9,460 - $10,673
-37 Reduced 1.17%
3,125 $900,000
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $46,135 - $57,278
-211 Reduced 6.26%
3,162 $849,000
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $67,737 - $82,560
-300 Reduced 8.17%
3,373 $815,000
Q4 2022

Feb 02, 2023
SELL
$229.03 - $291.01 $21,299 - $27,063
-93 Reduced 2.47%
3,673 $964,000
Q3 2022

Nov 09, 2022
BUY
$224.46 - $253.15 $8,305 - $9,366
37 Added 0.99%
3,766 $849,000
Q2 2022

Aug 10, 2022
SELL
$230.71 - $256.74 $22,148 - $24,647
-96 Reduced 2.51%
3,729 $907,000
Q1 2022

May 02, 2022
BUY
$219.27 - $242.57 $153,269 - $169,556
699 Added 22.36%
3,825 $925,000
Q3 2021

Nov 08, 2021
SELL
$212.27 - $248.7 $92,761 - $108,681
-437 Reduced 12.26%
3,126 $665,000
Q2 2021

Aug 03, 2021
SELL
$233.58 - $259.14 $93,432 - $103,656
-400 Reduced 10.09%
3,563 $868,000
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $45,491 - $53,013
205 Added 5.46%
3,963 $986,000
Q4 2020

Feb 12, 2021
BUY
$216.38 - $257.67 $29,860 - $35,558
138 Added 3.81%
3,758 $864,000
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $26,984 - $30,009
115 Added 3.28%
3,620 $920,000
Q2 2019

Aug 06, 2019
SELL
$166.7 - $195.41 $99,519 - $116,659
-597 Reduced 14.55%
3,505 $646,000
Q1 2019

May 01, 2019
SELL
$180.87 - $203.88 $11,394 - $12,844
-63 Reduced 1.51%
4,102 $779,000
Q3 2018

Nov 07, 2018
SELL
$185.29 - $208.89 $19,826 - $22,351
-107 Reduced 2.5%
4,165 $863,000
Q2 2018

Aug 01, 2018
SELL
$166.05 - $186.51 $223,835 - $251,415
-1,348 Reduced 23.99%
4,272 $789,000
Q1 2018

May 07, 2018
SELL
$169.43 - $198.0 $25,922 - $30,294
-153 Reduced 2.65%
5,620 $958,000
Q4 2017

Feb 09, 2018
SELL
$168.79 - $188.59 $533,376 - $595,944
-3,160 Reduced 35.37%
5,773 $1 Million
Q3 2017

Nov 06, 2017
BUY
$167.29 - $191.0 $1.49 Million - $1.71 Million
8,933
8,933 $1.67 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email